A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT04503213
Status
Enrolling By Invitation

Conditions

  • ALSP
  • CSF1R-related Leukoencephalopathy
  • Hematopoietic Stem Cell Transplantation
  • POLD

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to measure the effect of Hematopoietic Stem Cell Transplantation (HSCT) on symptoms of CSF1R-related Leukoencephalopathy.

Key Dates

Start date
Jul 21, 2020
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
20 participants (estimated)

Primary Outcome Measure

Improvement in cognitive and motor function [ Time Frame: Through study completion, approximately 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FL

Related Studies